Generic Semaglutide Canada 2026 | Plosbrio & Poviztra Providers

Provider Comparison

🏅 Highly Rated

9.93

From $149/month

Generic semaglutide (Plosbrio/Poviztra) — same active ingredient as Ozempic, up to 90% cheaper. · In-house telehealth clinic + in-house pharmacy: faster fulfilment, no third-party delays.

Visit Site →

Direct Meds

9.81

From $99/month

100% online medical visit — brand-name GLP-1 injections and oral options available. · Prescription and telehealth visits included. No insurance required.

Visit Site →

Felix Health

9.68

From $39/month

Canada-wide availability — serving all provinces. · Brand-name weight loss programs: Ozempic, Wegovy, Saxenda.

Visit Site →

Provider	Rating	Key Features	Price	Visit
MyRocky	9.93	Generic semaglutide (Plosbrio/Poviztra) — same active ingredient as Ozempic, up to 90% cheaper., In-house telehealth clinic + in-house pharmacy: faster fulfilment, no third-party delays.	From $149/month	Visit Site
Direct Meds	9.81	100% online medical visit — brand-name GLP-1 injections and oral options available., Prescription and telehealth visits included. No insurance required.	From $99/month	Visit Site
Felix Health	9.68	Canada-wide availability — serving all provinces., Brand-name weight loss programs: Ozempic, Wegovy, Saxenda.	From $39/month	Visit Site

Generic Semaglutide in Canada: What You Need to Know

Canada made history in 2025 by becoming the first G7 nation to approve generic semaglutide. Two manufacturers received Health Canada authorization: Dr. Reddy's Laboratories (Plosbrio) and Apotex Inc. (Poviztra). Both products contain the same active ingredient as Ozempic and are required to demonstrate bioequivalence before receiving approval.

For Canadians who have been priced out of brand-name GLP-1 medications, this approval has the potential to transform access. Health Canada has estimated that generic semaglutide will be 45-90% cheaper than brand-name Ozempic — though the full price impact will take 12-24 months to materialize as production scales and more generics enter the market.

Health Canada-Approved Generic Semaglutide Products

Plosbrio

Dr. Reddy's Laboratories (India)

One of the world's largest generic pharmaceutical manufacturers. Global operations in 66+ countries. Pre-filled injection pen, doses: 0.5 mg, 1 mg, 2 mg.

Poviztra

Apotex Inc. (Canada)

Canada's largest generic drug company, headquartered in North York, Ontario. Pre-filled injection pen, doses: 0.5 mg, 1 mg, 2 mg.

Compounded Semaglutide / Tirzepatide

Not permitted in Canada

Unlike the United States, Health Canada does not permit compounded GLP-1 weight loss injections. All providers in Canada offer only authorized brand-name or generic products.

What Does 'Generic' Actually Mean?

A Health Canada-approved generic drug must demonstrate bioequivalence to the reference product. This means it delivers the same amount of active ingredient into the bloodstream at the same rate, within an accepted statistical margin. The active molecule (semaglutide) is identical. The pen device and inactive ingredients may differ slightly — but the clinical effect is the same.

For patients currently on Ozempic, switching to a generic does not require a dose adjustment or a clinical restart. Your physician can write a new prescription for generic semaglutide, and you continue on your current dose schedule with the new product.

Frequently Asked Questions

Generic semaglutide refers to Health Canada-approved generic versions of injectable semaglutide — the active molecule in Ozempic. Canada approved two generics: Plosbrio (Dr. Reddy's Laboratories) and Poviztra (Apotex, Canada's largest generic manufacturer). Both are bioequivalent to Ozempic and expected to cost 45-90% less.

Yes, in terms of active ingredient. Generic semaglutide contains the same active molecule (semaglutide) at the same doses (0.5 mg, 1 mg, 2 mg). Health Canada requires bioequivalence — meaning the generic delivers the same amount of drug into the bloodstream at the same rate as the reference product (Ozempic). The pen device and excipients may differ slightly between manufacturers.

Health Canada estimates generic semaglutide will be 45-90% cheaper than brand-name Ozempic. At launch, prices may be closer to 25-40% below brand. As more generics enter the market and production scales over 12-24 months, prices are expected to fall further. MyRocky currently offers generic semaglutide from $149/month.

Generic semaglutide (Plosbrio and Poviztra) is approved for adults with type 2 diabetes. Physicians can also prescribe it off-label for weight management, as they do with Ozempic. A licensed Canadian physician must conduct a clinical assessment before prescribing. Eligibility typically requires a BMI of 30 or higher, or 27 or higher with a weight-related health condition.

No. Unlike the United States, Health Canada does not permit compounded versions of GLP-1 weight loss injections such as compounded semaglutide or tirzepatide. Canadian providers offer only Health Canada-approved products — either brand-name medications (Ozempic, Wegovy, Saxenda) or the newly approved generics (Plosbrio, Poviztra).

Generic Semaglutide in Canada

Key Takeaways for Canadian Patients

Generic Semaglutide Providers

Quick Links

Provider Comparison

Generic Semaglutide in Canada: What You Need to Know

Health Canada-Approved Generic Semaglutide Products

What Does 'Generic' Actually Mean?

Frequently Asked Questions

Compare Generic Semaglutide Providers in Canada